3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
63
Breast
46
Thoracic
44
Gynecologic
34
Genitourinary
28
Tumor-Agnostic
25
Other hematologic neoplasm
24
Lymphoid
23
Head & Neck
21
CNS
21
Dermatologic
16
Sarcoma
12
Plasma cell
9
Myeloid
5
Other solid neoplasm
3
NET
1
Endocrine
1
Classical hematology
1
Conditions
Midgut Neuroendocrine Tumors
1
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
Endoscopic Mucosal Resection
2
Data Collection
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Serum Albumin
1
Robotic Surgical Procedures
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Radiofrequency Ablation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Octreotide
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Drug Therapy
1
Diet Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Blood Specimen Collection
×
NET
×
Clear all
NCT03667092
2025-04-10
GENEBIOLuNET
University Hospital, Toulouse
Phase NA
Completed
47 enrolled